The General Administration of Market Supervision of the China Market said that it has filed 307 cases of illegal acts on the prices of immune -related drugs and medical supplies.rise.NotEconomic Daily Report A special press conference was held on Tuesday (December 20) to introduce the relevant situation of the stable price of drugs and medical supplies involving crown diseases.NotTian Shihong, deputy director of the General Administration of Market Supervision, revealed that in the past two weeks, the market supervision departments of various parts of China have focused on investigating and dealing with four types of rushing prices illegal acts such as "the sales price has not increased significantly without significantly increased the cost.The penalty was 2.581 million yuan (RMB, about N $ 490,000).NotThe General Administration of Market Supervision of the China Market has quickly curbed the problems such as the significant increase in prices of immune -related drugs and medical supplies.In particular, the first time they were organized and dealt with the prices of the Lianhua Qing Plague, 12 cases had been handed over to the local market supervision department to file a case.NotInstantic drugs and antigens production Deputy Director Huang Guo said that China ’s ibuprofen and the raw material for acetylphenols are relatively sufficient, and production agent companies are gradually releasing production capacity.The State Drug Administration has deployed relevant local pharmaceutical regulatory departments to serve, actively contacted relevant production enterprises, and expands production capacity in order to orderly.Up to now, the China Pharmaceutical Bureau has approved 42 antigen test agents, with a daily output of about 60 million people.NotYuan Xilu, director of the Price Supervision Bureau of the General Administration of Market Supervision, said that in a very short time, if each one needs to buy a little medicine, it will be a huge number. In addition, there is indeed an illegal behavior such as coaxing prices, hoarding and sale. This is caused by triggeringAt present, the important factor of "difficult to buy medicine and expensive medicine".Therefore, the problem of random price increases for immune -related drugs and medical supplies is still the primary task of the future period.NotIn one step, China will strengthen the key supervision of two aspects.On the one hand, to strengthen the supervision of the full -chain, not only attach importance to the supervision of the end market price, but also the price supervision of important raw materials, especially the price of Chinese medicinal materials.On the other hand, it attaches more importance to cracking down on illegal acts such as hoarding and more hidden market harm, and strives to maintain prices and competitive order.NotThe business platform is also the key supervisory object.The Chinese market regulatory authorities have carried out risk monitoring on the price of illegal prices, fakes, false propaganda, and unlicensed operations on the online sales of epidemic -related drugs and medical supplies on platforms such as JD.com, Tmall, Pinduoduo and other platforms.The regulatory authorities verify and investigate and deal with them in accordance with the law.
